These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 198298)

  • 1. Determination of antigen content and effectiveness of foor-and-mouth disease vaccines.
    Czelleng F; Sólyom F
    Dev Biol Stand; 1976; 35():295-6. PubMed ID: 198298
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Attempts at potency testing of foot-and-mouth disease vaccines by evaluation of the complement fixing capacity of eluates.
    Bauer K
    Dev Biol Stand; 1976; 35():297-300. PubMed ID: 198299
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An evalutation of some methods of assay of foot-and-mouth disease antigen for vaccines.
    Garland AJ; Mowat GN; Fletton B
    Dev Biol Stand; 1976; 35():323-32. PubMed ID: 198302
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Studies on the correct quantitative relations of antigen components in mono-, bi- and trivalent foot-and-mouth disease vaccine preparations.
    Sólyom F; Czelleng F
    Dev Biol Stand; 1976; 35():289-94. PubMed ID: 198297
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of laboratory techniques for the evaluation of the antigenic potency of foot-and-mouth disease virus cultures and vaccines.
    Terpstra C; Frenkel S; Straver PJ; Barteling SJ; van Bekkum JG
    Dev Biol Stand; 1976; 35():333-42. PubMed ID: 198304
    [No Abstract]   [Full Text] [Related]  

  • 6. [Study of the indirect complement fixation test for use in the differentiation of foot-and-mouth disease viruses and the determination of immunity].
    Tekerlekov P; Mitev G; Nikolova E
    Vet Med Nauki; 1975; 12(6):28-34. PubMed ID: 179191
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Development of a method for the quantitative determination of the immunizing antigen (140S) of the foot-and-mouth disease virus].
    Tekerlekov P; Vasileva L; Nikolova E; Veleva E
    Vet Med Nauki; 1985; 22(9):10-9. PubMed ID: 3002008
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Virus content and effectiveness of foot-and-mouth disease vaccines.
    Czelleng F; Sólyom F
    Acta Microbiol Acad Sci Hung; 1976; 23(1):77-81. PubMed ID: 180758
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The effectiveness of foot-and-mouth disease vaccines in Switzerland. II. Stability problems].
    Ackermann M; Müller HK; Bruckner L; Kihm U
    Schweiz Arch Tierheilkd; 1989; 131(7):389-95. PubMed ID: 2552580
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Possibilities of biophysicochemical antigen control in vaccine production using foot-and-mouth disease virus as an example (review)].
    Liebermann H; Kwasniowski W; Strebelow G
    Arch Exp Veterinarmed; 1988 Mar; 42(2):165-73. PubMed ID: 2840042
    [No Abstract]   [Full Text] [Related]  

  • 11. [Testing the activity of anti-foot-and-mouth disease vaccine in cattle: quantitative methods of antigenic extinction].
    Terré J; Stellmann C; Brun A; Favre H; Fontaine J
    Dev Biol Stand; 1976; 35():357-67. PubMed ID: 198306
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Verification of a method of standardization of the antigens of anti-aphthous vaccine based on complement fixation capacity].
    Strobbe R; Debecq J; Leunen J
    Bull Off Int Epizoot; 1969; 71(3-4):397-404. PubMed ID: 4323528
    [No Abstract]   [Full Text] [Related]  

  • 13. Detection of foot-and-mouth disease antigen in bovine epithelial samples: comparison of sites of sample collection by an enzyme linked immunosorbent assay (ELISA) and complement fixation test.
    Oliver RE; Donaldson AI; Gibson CF; Roeder PL; Le Blanc Smith PM; Hamblin C
    Res Vet Sci; 1988 May; 44(3):315-9. PubMed ID: 2841733
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The use of suspension cultures for FMD vaccine production. Criteria for the evaluation of cells, virus and vaccine.
    Nardelli L; Panina GF
    Dev Biol Stand; 1976; 35():9-25. PubMed ID: 198318
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The use of serum neutralizing antibody assay for the determination of the potency of foot and mouth disease (FMD) vaccines in cattle.
    Pay TW; Hingley PJ
    Dev Biol Stand; 1986; 64():153-61. PubMed ID: 3025036
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A micro-enzyme-lavelled immunosorbent assay (MICORELISA) for the detection of foot-and-mouth disease virus antigen and antibody.
    Rai A; Lahiri DK
    Acta Virol; 1981 Jan; 25(1):49-52. PubMed ID: 6112866
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Complement fixation micromethod for determining the type of foot-and-mouth disease virus].
    Gritsenko AI; Sobko AI; Chepurkina AI
    Veterinariia; 1975 Jan; (1):99-100. PubMed ID: 163522
    [No Abstract]   [Full Text] [Related]  

  • 18. [Preliminary study of the combination of anti-foot-and-mouth disease and anti-brucellosis vaccines].
    Mastan MB; Amighi M; Ardelan A; Bandpay MR; Ebadi A; Farsi J
    Dev Biol Stand; 1976; 35():437-43. PubMed ID: 198311
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reduction of animal usage in the control of foot-and-mouth disease vaccines.
    Strobbe R
    Dev Biol Stand; 1986; 64():163-7. PubMed ID: 3025037
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Demonstration of antibody-synthesizing cells in mice and swine by means of local hemolysis in gel following immunization with foot-and-mouth disease virus and vaccine].
    Wittmann G; Reda I
    Zentralbl Bakteriol Orig A; 1974; 227(1-4):420-5. PubMed ID: 4154623
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.